BRIEF: Bayzed Health to raise up to $115 million in Hong Kong IPO
Cancer hospital operator Bayzed Health Group Inc. (2609.HK) launched its Hong Kong IPO on Friday, aiming to raise up to HK$900 million ($115 million). The company said it plans to sell 133 million shares at between HK$4.22 and HK$6.75 per share, according to its announcement marking the listing’s launch.
Final pricing will take place on June 19, with trading set to begin on June 23.
Bayzed operates six self-owned hospitals around China engaged in the detection and treatment of cancer. The company reported 1.19 billion yuan ($166 million) in revenue last year, up 11% from 1.07 billion yuan in 2023. Its loss for 2024 narrowed to 13.5 million yuan from a 24.6 million yuan loss the previous year.
By Doug Young
To subscribe to Bamboo Works free weekly newsletter, click here
Related Articles
BRIEF: Jihong profit doubles in first three quarters of 2025
BRIEF: Alibaba stock rallies as Ark Invest buys back in
RELATED ARTICLES
-
BRIEF: Bayzed Health jumps in Hong Kong trading debut
2609.HK -
BRIEF: Green Economy invests $1.48 million in Bayed Health Group IPO
1315.HK 2609.HK
-
BRIEF: MetaLight bus app IPO finally stops in Hong Kong, to raise $31 million
2605.HK
- BRIEF: Newtrend launches Hong Kong IPO to raise up to $31 million
-
BRIEF: X.J. Electronics to raise up to $28 million in Hong Kong IPO
2619.HK
